Themis Medicare Ltd Gains 5.52%: 4 Key Factors Driving the Week’s Momentum

Monday, 29 June 2026: Week Opens Steady at Rs.112.25

Themis Medicare began the week at Rs.112.25, with a relatively low volume of 8,222 shares traded. The Sensex closed at 35,960.98, setting a baseline for the week’s performance. The stock was poised for movement amid anticipation of technical developments.

Tuesday, 30 June 2026: Golden Cross Formation and Technical Momentum Shift

On 30 June, Themis Medicare’s stock price declined by 2.63% to close at Rs.109.30, despite the formation of a significant Golden Cross technical pattern. This event, where the 50-day moving average crossed above the 200-day moving average, is widely regarded as a bullish signal indicating a potential long-term trend reversal. The Golden Cross suggested improving momentum, even as the stock faced short-term selling pressure.

Technical indicators presented a mixed picture: the daily moving averages were mildly bearish, while weekly MACD and Know Sure Thing (KST) oscillators remained bullish. The monthly MACD and Bollinger Bands, however, signalled caution with bearish tendencies. The stock traded with heavy volume of 52,758 shares, reflecting active investor interest amid this technical shift.

The Sensex was largely flat, closing marginally down by 0.01% at 35,958.71, underscoring the stock’s relative weakness on the day despite the positive technical signal.

Wednesday, 1 July 2026: Mojo Grade Upgraded to Hold Amid Mixed Financials

Themis Medicare’s stock rebounded modestly by 1.19% to close at Rs.110.60 on 1 July, supported by an upgrade in its MarketsMOJO rating from Sell to Hold. This upgrade reflected improving technical indicators, including a shift to bullish daily moving averages and a weekly MACD turning positive, despite lingering bearish monthly signals.

Financially, the company showed contrasting signals. Profit after tax surged by 316.91% to Rs.19.83 crores in the latest six months, and Profit Before Tax excluding other income grew by 187.5% in the recent quarter. However, operating profit remained negative at Rs.-9.94 crores, and the company’s Debt to EBITDA ratio was a concerning 100.09 times, indicating high leverage risk.

The stock traded with a volume of 9,013 shares, and the Sensex gained 0.45% to close at 36,119.01, reflecting a positive market backdrop.

Thursday, 2 July 2026: Sharp Price Surge of 7.73% to Rs.119.15

Themis Medicare experienced a strong rally on 2 July, surging 7.73% to Rs.119.15 on robust volume of 40,368 shares. This sharp gain aligned with the improving technical momentum, including bullish weekly MACD and KST indicators, and daily moving averages turning positive. The stock’s price approached the upper end of its recent trading range, signalling renewed investor confidence.

The Sensex also advanced by 0.71% to 36,376.02, supporting the broader market environment for gains.

Friday, 3 July 2026: Week Closes Slightly Lower at Rs.118.45

The stock closed the week at Rs.118.45, down 0.59% from the previous day’s close, on a volume of 14,625 shares. Despite the minor pullback, Themis Medicare ended the week with a strong 5.52% gain, significantly outperforming the Sensex’s 1.31% rise. The Sensex closed at 36,431.45, up 0.15% on the day.

The technical momentum remained cautiously optimistic, with daily moving averages bullish and weekly MACD positive, though monthly indicators continued to signal some caution. The stock’s micro-cap status and elevated valuation metrics suggest that investors should monitor developments closely.

Key Takeaways from the Week

Positive Signals: The formation of a Golden Cross on 30 June marked a pivotal technical event signalling potential sustained upward momentum. The upgrade in Mojo Grade from Sell to Hold on 1 July reflected improving technicals and cautious optimism. The sharp 7.73% price surge on 2 July demonstrated strong buying interest and momentum recovery. Year-to-date returns of 8.59% significantly outperformed the Sensex’s negative 10.26%, indicating resilience amid broader market weakness.

Cautionary Notes: Despite short-term improvements, monthly technical indicators such as MACD and Bollinger Bands remained bearish, suggesting longer-term headwinds. The company’s financial fundamentals showed mixed results, with impressive short-term profit growth but persistent operating losses and high leverage risk. The micro-cap status and elevated P/E ratio of 509.96 imply higher volatility and risk. Institutional interest remains limited, with no domestic mutual fund holdings reported.

Conclusion: A Week of Technical Progress Amid Financial Complexity

Themis Medicare Ltd’s performance over the week ending 3 July 2026 was characterised by a notable technical turnaround and a modest price appreciation of 5.52%, comfortably outperforming the Sensex. The Golden Cross formation and upgrade to a Hold rating by MarketsMOJO signal a potential shift in market sentiment towards cautious optimism. However, mixed financial results and persistent long-term technical caution counsel prudence.

Investors should closely monitor upcoming earnings, debt management progress, and sector developments to assess whether the emerging bullish momentum can be sustained. The stock’s micro-cap nature and valuation metrics warrant a balanced approach, integrating technical signals with fundamental analysis for informed decision-making.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →